RGAHX
Price
$87.22
Change
+$0.62 (+0.72%)
Updated
Sep 15 closing price
Net Assets
337.84B
SPECX
Price
$36.41
Change
+$0.42 (+1.17%)
Updated
Sep 15 closing price
Net Assets
4.34B
Interact to see
Advertisement

RGAHX vs SPECX

Header iconRGAHX vs SPECX Comparison
Open Charts RGAHX vs SPECXBanner chart's image
American Funds Growth Fund of Amer R5E
Price$87.22
Change+$0.62 (+0.72%)
VolumeN/A
Net Assets337.84B
Alger Spectra A
Price$36.41
Change+$0.42 (+1.17%)
VolumeN/A
Net Assets4.34B
RGAHX vs SPECX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RGAHX vs. SPECX commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGAHX is a Buy and SPECX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 338B vs. SPECX (4.34B). RGAHX pays higher dividends than SPECX: RGAHX (0.46) vs SPECX (0.00). RGAHX was incepted earlier than SPECX: RGAHX (10 years) vs SPECX (56 years). SPECX (1.52) is less costly to investors than RGAHX (0.44). SPECX is a more actively managed with annual turnover of: 49.26 vs. RGAHX (25.00). RGAHX has a lower initial minimum investment than SPECX: RGAHX (250) vs SPECX (1000). SPECX annual gain was more profitable for investors over the last year : 36.69 vs. RGAHX (17.06). RGAHX return over 5 years is better than : 46.38 vs. SPECX (26.41).
RGAHXSPECXRGAHX / SPECX
Total Expense Ratio0.441.5229%
Annual Report Gross Expense Ratio0.441.5229%
Fund Existence10 years56 years-
Gain YTD17.91926.54768%
Front LoadN/A5%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets338B4.34B7,792%
Annual Yield % from dividends0.460.00-
Returns for 1 year17.0636.6946%
Returns for 3 years62.47117.2053%
Returns for 5 years46.3826.41176%
Returns for 10 yearsN/A101.85-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNSP9.201.81
+24.49%
CNS Pharmaceuticals Inc
BGSF7.880.12
+1.55%
BGSF
WLY41.390.20
+0.49%
John Wiley & Sons
AROW29.100.10
+0.34%
Arrow Financial Corp
FN359.001.00
+0.28%
Fabrinet